Print this page    •   Back to Web version of article

Medical News
Large Trial of Tenofovir Gel for Women Set to Begin in South Africa

June 15, 2011

A 24-month clinical trial looking at the effectiveness of tenofovir gel use among women to reduce the risk of HIV infection is set to begin in South Africa in late July or early August, the Mail & Guardian reports.


The study, called Follow-on African Consortium for Tenofovir Studies (FACTS), aims to confirm the findings of the Caprisa 004 trial, which "found that a microbicide containing 1% tenofovir, if used before and after sex, reduced the chances of women contracting HIV by 39%" and halved the risk of contracting genital herpes, according to Business Day. But because Caprisa 004 involved a smaller number of women, "the findings had a wide margin of error, with the efficacy of HIV protection estimated to lie between 6% and 60%, said FACTS protocol chair Prof Helen Rees," the newspaper writes (Kahn, 6/15).

The FACTS trial, which will involve 2,200 sexually active women at seven sites in South Africa, will cost $300 million rand and be funded by the South African Departments of Science and Technology and Health and USAID, according to Times Live (Mclea, 6/14). In a USAID statement, Administrator Rajiv Shah said, "We believe confirming tenofovir gel's effectiveness and obtaining regulatory approval is a fundamental and essential step in that direction, and we look forward to supporting South Africa's leadership in this endeavor" (6/14).

Back to other news for June 2011

This information was reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.